NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting
NetworkNewsWire Announces Publication on Good News in Biotech Advancements Through Cannabis Delivery Technology
Immune Design to Report First Quarter 2018 Financial Results and Provide Corporate Update
Aptose Announces Appointment of Caroline M. Loewy to Board of Directors
Sharps Compliance Reports Fiscal 2018 Third Quarter Results
Sunniva Inc. to Delay Earnings Release Until April 30, 2018
Icon Media Holdings, Inc. Enters Into Joint Services Agreement with DMR Biologics
Intrommune Therapeutics to Present at Eighth Annual BioNJ BioPartnering Conference
Organovo to Present at 2nd Annual NASH Summit
Catalyst Pharmaceuticals Introduces New Corporate Website
Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference
Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO
Astaxanthin Market worth over $800 million by 2024: Global Market Insights, Inc.
Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation
NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
NetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine Delivery
FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®
Copyright © 1995-2018 CenterWatch.